Sc.M., Chief Business Officer, Cipherome
Biography
José Estabil is currently Chief Business Officer at Cipherome, a venture-backed AI/genomics company personalizing medicine to limit adverse drug reactions. José developed projects in Tokyo, Seoul and Moscow, directed MIT’s international innovation activities, and found an entrepreneurial outlet at MIT by advising the launch, scale, and exit of Arctic Sand (acq: Murata), an MIT spin-out. Before moving to Boston, José develop three award winning semiconductor diagnostics products (KLA) and ran $100M+ semiconductor businesses in Silicon Valley. He started his career at IBM labs.
Clinical Dx Showcase:
Cipherome
Cipherome is a venture-backed AI/genomics company personalizing medicine to limit adverse drug reactions. Xentinel(RM) Lighthouse is in a commercial pilot using Hispanic/Latinx patients in South Texas.
Is Clopidogrel Safe for All Patients?
Real world clinical application of Xentinel(RM) Lighthouse-guided antiplatelet therapy shows early success by improving patient outcomes, reducing unreimbursed costs, and avoiding "one more thing" for clinicians.
